Immix Biopharma (IMMX) director receives 6,250 RSUs and 12,500 options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Immix Biopharma director Nancy T. Chang reported new equity awards, not open‑market trades. She received 6,250 restricted stock units under the 2021 Equity Incentive Plan, which vest in full on the earlier of the one-year anniversary of grant or the company’s 2027 annual stockholders’ meeting, subject to continued service.
She was also granted stock options for 12,500 shares of common stock at an exercise price of $8.78 per share, expiring on May 22, 2036, vesting in substantially equal monthly installments over 12 months or, if earlier, on the 2027 annual meeting date. After these awards, she holds 428,190 common shares directly and 496,940 shares indirectly through Robinhood II, LP, where she is general manager and disclaims beneficial ownership except for her pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
CHANG NANCY T
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 12,500 | $0.00 | -- |
| Grant/Award | Common Stock | 6,250 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 12,500 shares (Direct, null);
Common Stock — 428,190 shares (Direct, null);
Common Stock — 496,940 shares (Indirect, Held by Robinhood II, LP)
Footnotes (1)
- The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held, subject to the Reporting Person's continued service with the Issuer. The Reporting Person is the general manager of Robinhood II, LP and may be deemed to beneficially own the securities held by Robinhood II, LP. The Reporting Person disclaims beneficial ownership of the common stock owned directly by Robinhood II, LP, except to the extent of her pecuniary interest therein. The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date.
Key Figures
RSUs granted: 6,250 units
Stock options granted: 12,500 options
Option exercise price: $8.78 per share
+3 more
6 metrics
RSUs granted
6,250 units
Restricted stock units granted under 2021 Equity Incentive Plan
Stock options granted
12,500 options
Options on common stock granted as director compensation
Option exercise price
$8.78 per share
Strike price for 12,500 stock options
Option expiration
May 22, 2036
Expiration date of stock options
Direct common shares after award
428,190 shares
Direct ownership following reported transactions
Indirect common shares
496,940 shares
Held by Robinhood II, LP associated with Nancy T. Chang
Key Terms
restricted stock units, 2021 Equity Incentive Plan, pecuniary interest, stock option, +1 more
5 terms
restricted stock units financial
"The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2021 Equity Incentive Plan financial
"granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan"
pecuniary interest financial
"disclaims beneficial ownership of the common stock owned directly by Robinhood II, LP, except to the extent of her pecuniary interest therein"
stock option financial
"The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
beneficially own financial
"may be deemed to beneficially own the securities held by Robinhood II, LP"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
FAQ
What equity awards did Immix Biopharma (IMMX) director Nancy T. Chang receive?
Nancy T. Chang received 6,250 restricted stock units and stock options for 12,500 shares of Immix Biopharma common stock. Both awards were granted as compensation, with the RSUs and options subject to specific vesting schedules tied to time and the 2027 annual stockholders’ meeting.
How do the 6,250 RSUs granted to Nancy T. Chang vest at Immix Biopharma (IMMX)?
The 6,250 RSUs vest in full on the earlier of one year after the grant date or the date of Immix Biopharma’s 2027 annual stockholders’ meeting. Vesting is contingent on Nancy T. Chang’s continued service with the company through the applicable vesting date.
What are the key terms of Nancy T. Chang’s 12,500 stock options at Immix Biopharma (IMMX)?
Nancy T. Chang’s 12,500 stock options have an exercise price of $8.78 per share and expire on May 22, 2036. They vest in substantially equal monthly installments over 12 months, or fully on the 2027 annual meeting date if that occurs earlier, subject to continued board service.
What is Robinhood II, LP’s role in Nancy T. Chang’s Immix Biopharma (IMMX) holdings?
Robinhood II, LP holds 496,940 Immix Biopharma shares reported as indirect holdings for Nancy T. Chang. She is the general manager and may be deemed to beneficially own those securities but formally disclaims beneficial ownership except to the extent of her pecuniary interest in the partnership.
Are Nancy T. Chang’s Form 4 transactions in Immix Biopharma (IMMX) open-market buys or sales?
The Form 4 shows compensation-related acquisitions, not open-market trades. Nancy T. Chang received RSUs and stock options at no cash cost per share, with vesting tied to time and service, and one entry reflects existing indirect holdings through Robinhood II, LP rather than new market purchases or sales.